Merck KGaA Buys Serono, Gaining U.S. Commercial Organization
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck acquires family-owned shares representing 64.5% of Serono's capital and will launch a tender offer for the remainder, at a total value of $13.27 bil.